These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8501181)

  • 21. Gonadotropin-releasing hormone agonists and estrogen-progestogen replacement therapy.
    Barbieri RL
    Am J Obstet Gynecol; 1990 Feb; 162(2):593-5. PubMed ID: 2137979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of uterine fibroids with agonist analogs of gonadotropin-releasing hormone.
    Kessel B; Liu J; Mortola J; Berga S; Yen SS
    Fertil Steril; 1988 Mar; 49(3):538-41. PubMed ID: 3277869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of a gonadotropin-releasing hormone agonist to manage perimenopausal women with symptomatic uterine myomas.
    Wang PH; Lee WL; Cheng MH; Yen MS; Chao KC; Chao HT
    Taiwan J Obstet Gynecol; 2009 Jun; 48(2):133-7. PubMed ID: 19574174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leuprolide depot before myomectomy.
    Fribourg S
    Fertil Steril; 1990 Apr; 53(4):754. PubMed ID: 2108064
    [No Abstract]   [Full Text] [Related]  

  • 25. A randomized, placebo-controlled, double-blind study evaluating the efficacy of leuprolide acetate depot in the treatment of uterine leiomyomata.
    Friedman AJ; Harrison-Atlas D; Barbieri RL; Benacerraf B; Gleason R; Schiff I
    Fertil Steril; 1989 Feb; 51(2):251-6. PubMed ID: 2492232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The medical management of abnormal uterine bleeding in reproductive-aged women.
    Bradley LD; Gueye NA
    Am J Obstet Gynecol; 2016 Jan; 214(1):31-44. PubMed ID: 26254516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnetic resonance imaging of leiomyomata uteri: assessing therapy with the gonadotropin-releasing hormone agonist leuprolide.
    Lubich LM; Alderman MG; Ros PR
    Magn Reson Imaging; 1991; 9(3):331-4. PubMed ID: 1908932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Short-term therapy of uterine fibromyomatosis with GN-Rh analog].
    Massacesi M; Milkowski M; Gianfranceschi C; Massacesi L
    Minerva Ginecol; 1992 Dec; 44(12):641-4. PubMed ID: 1491772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medical treatment of uterine myoma with long-acting gonadotropin-releasing hormone agonist prior to myomectomy.
    Liu CH; Lin YS; Lin CC; Tzeng CC; Chou CY
    J Formos Med Assoc; 1993 Jun; 92(6):536-9. PubMed ID: 8106041
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful management of predicted severe ovarian hyperstimulation syndrome with gonadotropin-releasing hormone agonist.
    Wu TC; Gelety TJ; Jih MH; Fournet N; Buyalos R
    J Assist Reprod Genet; 1992 Jun; 9(3):281-3. PubMed ID: 1525462
    [No Abstract]   [Full Text] [Related]  

  • 31. Danazol administration after gonadotrophin-releasing hormone analogue reduces rebound of uterine myomas.
    De Leo V; Morgante G; Lanzetta D; D'Antona D; Bertieri RS
    Hum Reprod; 1997 Feb; 12(2):357-60. PubMed ID: 9070725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gonadotrophin-releasing hormone agonist and laparoscopic myomectomy.
    Dubuisson JB; Lecuru F; Foulot H; Mandelbrot L; Bouquet de la Jolinière J; Aubriot FX
    Clin Ther; 1992; 14 Suppl A():51-6. PubMed ID: 1535022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of leiomyomata with intranasal or subcutaneous leuprolide, a gonadotropin-releasing hormone agonist.
    Friedman AJ; Barbieri RL; Benacerraf BR; Schiff I
    Fertil Steril; 1987 Oct; 48(4):560-4. PubMed ID: 3115833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A placebo-controlled trial of a depot gonadotropin-releasing hormone analogue (leuprolide) in the treatment of uterine leiomyomata.
    Schlaff WD; Zerhouni EA; Huth JA; Chen J; Damewood MD; Rock JA
    Obstet Gynecol; 1989 Dec; 74(6):856-62. PubMed ID: 2511532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gonadotropin-releasing hormone agonist (leuprolide acetate) induced ovarian hyperstimulation syndrome in a woman undergoing intermittent hemodialysis.
    Hampton HL; Whitworth NS; Cowan BD
    Fertil Steril; 1991 Feb; 55(2):429-31. PubMed ID: 1899400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of uterine leiomyoma with depot leuprorelin acetate (Enantone-Gyn monthly depot). Effect on leiomyoma volume and operability. German Leuprorelin Study Group].
    Stolz W; Pfützenreuter N
    Zentralbl Gynakol; 1997; 119(10):468-75. PubMed ID: 9432825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postoperative GnRH analog treatment for the prevention of recurrences of uterine myomas after myomectomy. A pilot study.
    Vavala V; Lanzone A; Monaco A; Scribanti A; Guida C; Mancuso S
    Gynecol Obstet Invest; 1997; 43(4):251-4. PubMed ID: 9194624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reversible bone loss in women treated with GnRH-agonists for endometriosis and uterine leiomyoma.
    Waibel-Treber S; Minne HW; Scharla SH; Bremen T; Ziegler R; Leyendecker G
    Hum Reprod; 1989 May; 4(4):384-8. PubMed ID: 2526152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histopathological changes in leiomyomata treated with leuprolide acetate.
    Upadhyaya NB; Doody MC; Googe PB
    Fertil Steril; 1990 Nov; 54(5):811-4. PubMed ID: 2121550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Analogs of gonadoliberin in the treatment of endometriosis and uterine myoma. Comparison of daily subcutaneous treatment and intramuscular depot therapy].
    Horský J; Cerný M; Dvorák P; Lepová B; Zizkovský V; Vondrácek J
    Cesk Gynekol; 1989 Aug; 54(7):486-95. PubMed ID: 2529980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.